News
Growing traction and growing team for Redbiotec’s oncology program
Redbiotec recently hired three additional scientists supporting Redbiotec’s fast growing oncology program. We are happy to observe a big and growing interest in Redbiotec’s COMOS and in Redbiotec’s engineered bacteria. As a consequence Redbiotec will invest further resources in these promising immuno-oncology platforms. Redbiotec is currently also evaluating additional people strengthening its scientific advisory board.
Large portfolio of novel bacteria to fight cancer
Redbiotec is currently engineering and producing a number of novel bacteria strains. These strains are expected to show superior features in Redbiotec’s COMOs and in further applications. Based on the current and upcoming results Redbiotec plans to file an additional patent application by Q4 2018.
The Summit summit – World record holder Dani Arnold for fastest Matterhorn climb boosting Redbiotec
Dani Arnold, one of world’s top mountaineers and climbers, world speed record holder of Matterhorn North Face (1h 46min), joins Redbiotec in its headquarters. In its over ten years since foundation the Redbiotec team climbed multiple Swiss mountains. Reaching out for summits and facing physical and mental challenges has always been one of Redbiotec’s passions. “We simply adore the mountains. They are beautiful, and beautiful things motivate”, Christian Schaub, CEO of Redbiotec says, “Our summer and winter trips into the Swiss Alpes inspire our team and make us robust for reaching our high goals in our labs. We are deeply honored that Dani Arnold shared his extraordinary and outstanding achievements with Redbiotec and even trained Redbiotec’s team in improving its climbing skills. We are very much looking forward to a hopefully long lasting partnership and are convinced Dani will further boost our exciting business and helps us setting our goals very high”.
“Redbiotec and I share the same values and mindset. We both want to have a big impact on our sectors. We both seek for the biggest challenges, we never give up, while always trying to stay humble“, Dani Arnold says. “I’m very proud of being part of Redbiotec’s story”.
Upgrade of Redbiotec’s operations to biosafety level 2 plus (BSL-2+)
Redbiotec has successfully upgraded its infrastructure adding additional labs to biosafety level 2 plus (BSL-2+). This is an important step for Redbiotec, as our company is now allowed, among others, to make all the needed genetic engineering of our bacteria of interest such as E. coli and Salmonella as well as oncolytic viruses in-house. Together with the ongoing fruitful partnerships with leading research organizations globally, Redbiotec has a strong position in combining microorganims to fight cancer. The main medical application of Redbiotec’s cancer program is to reduce cancer recurrences. Please find more information here.
Cancer Research Expert joining Redbiotec
Redbiotec is pleased to announce the appointment of Prof. Mark Tangney, PhD, MBA, Principal Investigator Cork Cancer Research Centre, Irland, as additional exclusive advisor to Redbiotec. Mark is Vice-President of the Irish Society for Gene and Cell Therapy (ISGCT). As a renowned expert in the development of microbes as therapeutics he is a very valuable collaboration partner for Redbiotec’s current and future work in oncology. In particular, Redbiotec will profit a lot from Mark Tangney’s work on the associations between bacteria and cancer.